We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
676

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCM icon
3601
HUTCHMED
HCM
$2.12B
$21K ﹤0.01%
588
-10
-2% -$325
HRMY icon
3602
Harmony Biosciences
HRMY
$2.22B
$21K ﹤0.01%
484
+38
+9% +$1.51K
HVT.A icon
3603
Haverty Furniture Companies Class A
HVT.A
$21K ﹤0.01%
711
-1,163
-62% -$37.9K
IGIC icon
3604
International General Insurance
IGIC
$1.16B
$21K ﹤0.01%
+2,568
New +$21.1K
IMRX icon
3605
Immuneering
IMRX
$327M
$21K ﹤0.01%
1,310
+1,077
+462% +$26.2K
ISPC icon
3606
iSpecimen
ISPC
$3.23M
$21K ﹤0.01%
3
+1
+50% +$7.18K
JOE icon
3607
St. Joe Company
JOE
$3.89B
$21K ﹤0.01%
395
-3,380
-90% -$164K
MOD icon
3608
Modine Manufacturing
MOD
$11.1B
$21K ﹤0.01%
2,113
-28,629
-93% -$319K
NWPX icon
3609
NWPX Infrastructure Inc
NWPX
$1.12B
$21K ﹤0.01%
670
+349
+109% +$9.61K
PUBM icon
3610
PubMatic
PUBM
$801M
$21K ﹤0.01%
607
+531
+699% +$17.3K
QGEN icon
3611
Qiagen
QGEN
$8.87B
$21K ﹤0.01%
359
-5,235
-94% -$300K
RCKY icon
3612
Rocky Brands
RCKY
$356M
$21K ﹤0.01%
527
-150
-22% -$6.48K
RMNI icon
3613
Rimini Street
RMNI
$466M
$21K ﹤0.01%
3,604
+2,177
+153% +$17.1K
ROOT icon
3614
Root
ROOT
$797M
$21K ﹤0.01%
384
+356
+1,271% +$27.8K
RWAY icon
3615
Runway Growth Finance
RWAY
$290M
$21K ﹤0.01%
+1,645
New +$21.3K
SCO icon
3616
ProShares UltraShort Bloomberg Crude Oil
SCO
$594M
$21K ﹤0.01%
84
-2,388
-97% -$655K
SFL icon
3617
SFL Corp
SFL
$1.64B
$21K ﹤0.01%
2,491
-5,341
-68% -$44.4K
SNBR
3618
DELISTED
Sleep Number
SNBR
$21K ﹤0.01%
274
-1,697
-86% -$142K
FTH
3619
Faeth Therapeutics
FTH
$836M
$21K ﹤0.01%
181
+142
+364% +$21.2K
TBBK icon
3620
The Bancorp
TBBK
$2.84B
$21K ﹤0.01%
815
-3,088
-79% -$89K
TCBK icon
3621
TriCo Bancshares
TCBK
$1.84B
$21K ﹤0.01%
495
-42
-8% -$1.84K
TK icon
3622
Teekay
TK
$1.09B
$21K ﹤0.01%
6,893
+986
+17% +$3.4K
URA icon
3623
Global X Uranium ETF
URA
$6.27B
$21K ﹤0.01%
+907
New +$23.9K
URG
3624
Ur-Energy
URG
$537M
$21K ﹤0.01%
17,133
+11,363
+197% +$18.6K
URGN icon
3625
UroGen Pharma
URGN
$2.36B
$21K ﹤0.01%
2,205
+1,605
+268% +$22.6K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 676 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.